Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.75 is in line with its 5-year average of 0.72, near the high end of its 5-year range (0.48–0.85).
As of the fiscal period ended Tuesday, March 31, 2026. 4.42% above its 12-month average of 0.72.
Reported quarterly debt to equity ratio; no daily interpolation.
DEBT TO EQUITY RATIO
0.75
DEBT TO EQUITY RATIO AVG TTM
0.72
DEBT TO EQUITY RATIO AVG 3Y
0.73
DEBT TO EQUITY RATIO AVG 5Y
0.75
DEBT TO EQUITY RATIO AVG 10Y
0.61
DEBT TO EQUITY RATIO AVG 15Y
0.50
DEBT TO EQUITY RATIO AVG 20Y
0.48
CURRENT VS TTM AVG
+4.42%
CURRENT VS 3Y AVG
+2.70%
CURRENT VS 5Y AVG
+0.74%
CURRENT VS 10Y AVG
+23.23%
CURRENT VS 15Y AVG
+49.90%
CURRENT VS 20Y AVG
+56.49%
SECTOR MEDIAN · HEALTHCARE
0.67
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+12.41%
vs the sector median at left
Market Cap
$47.58B
Debt to Equity Ratio
0.07
TTM Avg
0.07
3Y Avg
0.09
5Y Avg
0.11
Market Cap
$42.94B
Debt to Equity Ratio
0.67
TTM Avg
0.65
3Y Avg
1.10
5Y Avg
1.25
Market Cap
$53.41B
Debt to Equity Ratio
-3.36
TTM Avg
3.77
3Y Avg
2.58
5Y Avg
2.11
Market Cap
$39.14B
Debt to Equity Ratio
0.50
TTM Avg
0.55
3Y Avg
0.53
5Y Avg
0.52
Market Cap
$56.65B
Debt to Equity Ratio
0.76
TTM Avg
0.79
3Y Avg
0.73
5Y Avg
0.74
Market Cap
$36.28B
Debt to Equity Ratio
1.62
TTM Avg
21.25
3Y Avg
21.25
5Y Avg
11.18
Market Cap
$34.72B
Debt to Equity Ratio
2.49
TTM Avg
2.41
3Y Avg
2.34
5Y Avg
2.26
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $46.74B | 0.75 | 0.72 | 0.73 | 0.75 |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 0.07 | 0.07 | 0.09 | 0.11 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $42.94B | 0.67 | 0.65 | 1.10 | 1.25 |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | -3.36 | 3.77 | 2.58 | 2.11 |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 0.50 | 0.55 | 0.53 | 0.52 |
| Becton, Dickinson and Company (BDX)vs › | $56.65B | 0.76 | 0.79 | 0.73 | 0.74 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 1.62 | 21.25 | 21.25 | 11.18 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 2.49 | 2.41 | 2.34 | 2.26 |
| Cencora, Inc. (COR)vs › | $60.29B | 7.13 | 8.71 | 10.16 | 17.42 |
| Medline Inc. (MDLN)vs › | $32.77B | 1.17 | 1.09 | 0.79 | 0.79 |
Debt/Equity
0.75
Current Ratio
0.72
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-03-31 | 0.75 |
| 2025-12-31 | 0.73 |
| 2025-09-30 | 0.68 |
| 2025-06-30 | 0.69 |
| 2025-03-31 | 0.75 |
| 2024-12-31 | 0.75 |
| 2024-09-30 | 0.74 |
| 2024-06-30 | 0.77 |
| 2024-03-31 | 0.82 |
| 2023-12-31 | 0.75 |
| 2023-09-30 | 0.69 |
| 2023-06-30 | 0.70 |
| 2023-03-31 | 0.70 |
| 2022-12-31 | 0.77 |
| 2022-09-30 | 0.65 |
| 2022-06-30 | 0.83 |
| 2022-03-31 | 0.85 |
| 2021-12-31 | 0.82 |
| 2021-09-30 | 0.75 |
| 2021-06-30 | 0.48 |
| 2021-03-31 | 0.51 |
| 2020-12-31 | 0.52 |
| 2020-09-30 | 0.49 |
| 2020-06-30 | 0.54 |
| 2020-03-31 | 0.64 |
| 2019-12-31 | 0.51 |
| 2019-09-30 | 0.56 |
| 2019-06-30 | 0.52 |
| 2019-03-31 | 0.60 |
| 2018-12-31 | 0.60 |
| 2018-09-30 | 0.49 |
| 2018-06-30 | 0.51 |
| 2018-03-31 | 0.51 |
| 2017-12-31 | 0.50 |
| 2017-09-30 | 0.44 |
| 2017-06-30 | 0.45 |
| 2017-03-31 | 0.51 |
| 2016-12-31 | 0.38 |
| 2016-09-30 | 0.36 |
| 2016-06-30 | 0.35 |
| 2016-03-31 | 0.36 |
| 2015-12-31 | 0.37 |
| 2015-09-30 | 0.37 |
| 2015-06-30 | 0.38 |
| 2015-03-31 | 0.38 |
| 2014-12-31 | 0.40 |
| 2014-09-30 | 0.38 |
| 2014-06-30 | 0.26 |
| 2014-03-31 | 0.27 |
| 2013-12-31 | 0.28 |
| 2013-09-30 | 0.27 |
| 2013-06-30 | 0.28 |
| 2013-03-31 | 0.28 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.22 |
| 2012-06-30 | 0.22 |
| 2012-03-31 | 0.23 |
| 2011-12-31 | 0.24 |
| 2011-09-30 | 0.25 |
| 2011-06-30 | 0.25 |
| 2011-03-31 | 0.27 |
| 2010-12-31 | 0.30 |
| 2010-09-30 | 0.28 |
| 2010-06-30 | 0.30 |
| 2010-03-31 | 0.31 |
| 2009-12-31 | 0.36 |
| 2009-09-30 | 0.34 |
| 2009-06-30 | 0.36 |
| 2009-03-31 | 0.47 |
| 2008-12-31 | 0.48 |
| 2008-09-30 | 0.45 |
| 2008-06-30 | 0.46 |
| 2008-03-31 | 0.47 |
| 2007-12-31 | 0.49 |
| 2007-09-30 | 0.41 |
| 2007-06-30 | 0.44 |
| 2007-03-31 | 0.51 |
| 2006-12-31 | 0.51 |
| 2006-09-30 | 0.43 |
| 2006-06-30 | 0.51 |
| 2006-03-31 | 0.46 |
| 2005-12-31 | 0.44 |
| 2005-09-30 | 0.37 |
| 2005-06-30 | 0.46 |
| 2005-03-31 | 0.49 |
| 2004-12-31 | 0.40 |
| 2004-09-30 | 0.37 |
| 2004-06-30 | 0.42 |
| 2004-03-31 | 0.45 |
| 2003-12-31 | 0.47 |
| 2003-09-30 | 0.65 |
| 2003-06-30 | 0.55 |
| 2003-03-31 | 0.59 |
| 2002-12-31 | 0.44 |
| 2002-09-30 | 0.44 |
| 2002-06-30 | 0.46 |
